Stockreport

IceCure's ProSense® Cryoablation System Receives Regulatory Approval in Switzerland for Indications Including Breast, Lung, Liver, and Kidney Cancer

IceCure Medical Ltd. - Ordinary Shares  (ICCM) 
PDF This latest approval further broadens global access to ProSense® and supports IceCure's commercial momentum following the U.S. Food and [Read more]